agilon health, inc. (AGL) Current Ratio
- Current ratio · latest quarter: Value 1.08×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 1.08× | Current assets / current liabilities. $1.42B ÷ $1.31B ≈ 1.08× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 1.42B USD | Assets, Current |
| Current obligations | 1.31B USD | Liabilities, Current |
| Cash and equivalents | 107.18M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current |
| Customer receivables | (m) | |
| Inventory | (m) | |
| Payables | (m) | |
| Borrowing debt due within one year | 14.91M USD | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.42B | $1.31B | $107.18M | (m) | (m) | (m) | (m) | $14.91M | 1.08× |
| 2026-03-31 | $1.32B | $1.27B | $139.99M | (m) | (m) | (m) | (m) | $14.75M | 1.04× |
| 2025-12-31 | $1.10B | $1.08B | $173.71M | (m) | (m) | (m) | (m) | $19.24M | 1.02× |
| 2025-09-30 | $1.34B | $1.24B | $171.68M | (m) | (m) | (m) | (m) | $34.97M | 1.08× |
| 2025-06-30 | $1.45B | $1.25B | $171.42M | (m) | (m) | (m) | (m) | $34.95M | 1.16× |
| 2025-03-31 | $1.65B | $1.37B | $136.94M | (m) | (m) | (m) | (m) | $34.92M | 1.20× |
| 2024-12-31 | $1.46B | $1.15B | $188.23M | (m) | (m) | (m) | (m) | $0.00 | 1.27× |
| 2024-09-30 | $1.81B | $1.41B | $148.16M | (m) | (m) | (m) | (m) | (m) | 1.29× |
| 2024-06-30 | $1.88B | $1.39B | $109.49M | (m) | (m) | (m) | (m) | $8.75M | 1.36× |
| 2024-03-31 | $2.04B | $1.53B | $111.71M | (m) | (m) | (m) | (m) | $7.50M | 1.33× |
| 2023-12-31 | $1.48B | $977.16M | $107.57M | (m) | (m) | (m) | (m) | (m) | 1.51× |
| 2023-09-30 | $1.96B | $1.30B | $168.34M | (m) | (m) | (m) | (m) | $5.00M | 1.50× |
| 2023-06-30 | $2.04B | $1.36B | $190.98M | (m) | (m) | (m) | (m) | $5.00M | 1.50× |
| 2023-03-31 | $1.88B | $972.61M | $394.19M | $422.49M | (m) | (m) | (m) | $5.00M | 1.93× |
| 2022-12-31 | $1.45B | $535.09M | $465.30M | (m) | (m) | (m) | (m) | $5.00M | 2.71× |
| 2022-09-30 | $1.63B | $658.23M | $551.29M | $407.99M | (m) | (m) | (m) | $5.00M | 2.48× |
| 2022-06-30 | $1.60B | $605.09M | $668.57M | $285.59M | (m) | (m) | (m) | $5.00M | 2.65× |
| 2022-03-31 | $1.63B | $610.46M | $1.02B | (m) | (m) | (m) | (m) | $5.00M | 2.67× |
| 2021-12-31 | $1.37B | $356.96M | $1.04B | $0.00 | (m) | (m) | (m) | $5.00M | 3.83× |
| 2021-09-30 | $1.45B | $422.78M | $1.08B | (m) | (m) | (m) | (m) | $5.00M | 3.44× |
| 2021-06-30 | $1.48B | $412.33M | $1.11B | (m) | (m) | (m) | (m) | $3.75M | 3.59× |
| 2021-03-31 | $417.63M | $372.11M | $105.29M | (m) | (m) | (m) | (m) | (m) | 1.12× |
| 2020-12-31 | $294.20M | $266.83M | $106.80M | (m) | (m) | (m) | (m) | $3.04M | 1.10× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |